Showing 381 - 400 results of 519 for search 'Abdullah of Saudi Arabia', query time: 0.08s Refine Results
  1. 381
  2. 382
  3. 383
  4. 384
  5. 385
  6. 386
  7. 387
  8. 388
  9. 389
  10. 390
  11. 391
  12. 392
  13. 393
  14. 394
  15. 395
  16. 396
  17. 397
  18. 398

    Safety and Efficacy of Combination Therapy with Anti-Vascular Endothelial Growth Factor and Laser for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis by Alamoudi A, Alnabihi AN, Alsudais AS, Almufarriji N, Batais WT, Aldahlawi AK, Altalhi A, Al-Dhibi HA, Alakeely AG

    Published 2025-01-01
    “…Anas Alamoudi,1 Ahmed N Alnabihi,2,3 Ali Saleh Alsudais,2,3 Naif Almufarriji,1 Waleed T Batais,2,3 Abdulaziz Khalid Aldahlawi,2,3 Abdullah Altalhi,4 Hassan A Al-Dhibi,5 Adel G Alakeely6 1Department of Ophthalmology, Jeddah Eye Hospital, Jeddah, Saudi Arabia; 2College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; 3King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; 4Division of Vitreoretinal Surgery, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; 5Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; 6Magrabi Hospitals and Centers, Riyadh, Saudi ArabiaCorrespondence: Anas Alamoudi, Department of Ophthalmology, Jeddah Eye Hospital, Jeddah, Saudi Arabia, Email anasalamoudi99@gmail.comAim: This systematic review and meta-analysis aimed to evaluate the safety and efficacy of combined laser and anti-VEGF therapy for (retinopathy of prematurity ROP), focusing on both structural and functional outcomes.Methods: A comprehensive search was conducted in multiple databases to identify randomized controlled trials (RCTs) that investigated combination therapy for ROP. …”
    Get full text
    Article
  19. 399
  20. 400